Skip to main content
Journal cover image

How many patients do you need? Investigating trial designs for anti-seizure treatment in acute brain injury patients.

Publication ,  Journal Article
Parikh, H; Sun, H; Amerineni, R; Rosenthal, ES; Volfovsky, A; Rudin, C; Westover, MB; Zafar, SF
Published in: Annals of clinical and translational neurology
July 2024

Epileptiform activity (EA), including seizures and periodic patterns, worsens outcomes in patients with acute brain injuries (e.g., aneurysmal subarachnoid hemorrhage [aSAH]). Randomized control trials (RCTs) assessing anti-seizure interventions are needed. Due to scant drug efficacy data and ethical reservations with placebo utilization, and complex physiology of acute brain injury, RCTs are lacking or hindered by design constraints. We used a pharmacological model-guided simulator to design and determine the feasibility of RCTs evaluating EA treatment.In a single-center cohort of adults (age >18) with aSAH and EA, we employed a mechanistic pharmacokinetic-pharmacodynamic framework to model treatment response using observational data. We subsequently simulated RCTs for levetiracetam and propofol, each with three treatment arms mirroring clinical practice and an additional placebo arm. Using our framework, we simulated EA trajectories across treatment arms. We predicted discharge modified Rankin Scale as a function of baseline covariates, EA burden, and drug doses using a double machine learning model learned from observational data. Differences in outcomes across arms were used to estimate the required sample size.Sample sizes ranged from 500 for levetiracetam 7 mg/kg versus placebo, to >4000 for levetiracetam 15 versus 7 mg/kg to achieve 80% power (5% type I error). For propofol 1 mg/kg/h versus placebo, 1200 participants were needed. Simulations comparing propofol at varying doses did not reach 80% power even at samples >1200.Our simulations using drug efficacy show sample sizes are infeasible, even for potentially unethical placebo-control trials. We highlight the strength of simulations with observational data to inform the null hypotheses and propose use of this simulation-based RCT paradigm to assess the feasibility of future trials of anti-seizure treatment in acute brain injury.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Annals of clinical and translational neurology

DOI

EISSN

2328-9503

ISSN

2328-9503

Publication Date

July 2024

Volume

11

Issue

7

Start / End Page

1681 / 1690

Related Subject Headings

  • Subarachnoid Hemorrhage
  • Seizures
  • Research Design
  • Randomized Controlled Trials as Topic
  • Propofol
  • Middle Aged
  • Male
  • Levetiracetam
  • Humans
  • Female
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Parikh, H., Sun, H., Amerineni, R., Rosenthal, E. S., Volfovsky, A., Rudin, C., … Zafar, S. F. (2024). How many patients do you need? Investigating trial designs for anti-seizure treatment in acute brain injury patients. Annals of Clinical and Translational Neurology, 11(7), 1681–1690. https://doi.org/10.1002/acn3.52059
Parikh, Harsh, Haoqi Sun, Rajesh Amerineni, Eric S. Rosenthal, Alexander Volfovsky, Cynthia Rudin, M Brandon Westover, and Sahar F. Zafar. “How many patients do you need? Investigating trial designs for anti-seizure treatment in acute brain injury patients.Annals of Clinical and Translational Neurology 11, no. 7 (July 2024): 1681–90. https://doi.org/10.1002/acn3.52059.
Parikh H, Sun H, Amerineni R, Rosenthal ES, Volfovsky A, Rudin C, et al. How many patients do you need? Investigating trial designs for anti-seizure treatment in acute brain injury patients. Annals of clinical and translational neurology. 2024 Jul;11(7):1681–90.
Parikh, Harsh, et al. “How many patients do you need? Investigating trial designs for anti-seizure treatment in acute brain injury patients.Annals of Clinical and Translational Neurology, vol. 11, no. 7, July 2024, pp. 1681–90. Epmc, doi:10.1002/acn3.52059.
Parikh H, Sun H, Amerineni R, Rosenthal ES, Volfovsky A, Rudin C, Westover MB, Zafar SF. How many patients do you need? Investigating trial designs for anti-seizure treatment in acute brain injury patients. Annals of clinical and translational neurology. 2024 Jul;11(7):1681–1690.
Journal cover image

Published In

Annals of clinical and translational neurology

DOI

EISSN

2328-9503

ISSN

2328-9503

Publication Date

July 2024

Volume

11

Issue

7

Start / End Page

1681 / 1690

Related Subject Headings

  • Subarachnoid Hemorrhage
  • Seizures
  • Research Design
  • Randomized Controlled Trials as Topic
  • Propofol
  • Middle Aged
  • Male
  • Levetiracetam
  • Humans
  • Female